Abstract #2813
In-vivo tracking of 19 F-labeled natural killer cells with MRI in lymphoid tumor model
Kai D. Ludwig 1 , Jeremy W. Gordon 1 , Myriam N. Bouchlaka 2 , Christian M. Capitini 2 , Bryan P. Bednarz 1,3 , and Sean B. Fain 1,3
1
Medical Physics, University of
Wisconsin-Madison, Madison, Wisconsin, United States,
2
Pediatrics,
University of Wisconsin-Madison, Madison, Wisconsin,
United States,
3
Radiology, University of
Wisconsin-Madison, Madison, Wisconsin, United States
Tumor-specific immunotherapy is emerging as a novel
treatment paradigm for patients with metastatic tumors
that are incurable with conventional therapies. Natural
killer (NK) cells have shown anti-tumor effects against
hematological and non-hematological cancers. Often, lack
of knowledge on trafficking patterns limits the efficacy
of adoptively transferred NK cells anti-tumor response.
We propose to use an MRI tracer perfluoropolyether agent
to detect immune cells in-vivo. Isolated,
19
F-labeled
NK cells were injected into a mouse and
19
F
MRI detected signal accumulation in a lymphoid tumor.
However,
19
F
signal contamination was observed from isoflurane
anesthetic requiring ketamine/xylazine as an anesthetic
in future work.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Click here for more information on becoming a member.
